Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
13.03
-0.34 (-2.54%)
Mar 3, 2026, 4:00 PM EST - Market closed
Orthofix Medical Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Orthofix Medical stock have an average target of 18.25, with a low estimate of 14 and a high estimate of 22. The average target predicts an increase of 40.06% from the current stock price of 13.03.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Orthofix Medical stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $24 → $20 | Strong Buy | Maintains | $24 → $20 | +53.49% | Feb 26, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | +30.47% | Feb 25, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $18 | Buy | Maintains | $18 | +38.14% | Feb 17, 2026 |
| TD Cowen | TD Cowen | Hold Initiates $14 | Hold | Initiates | $14 | +7.44% | Jan 27, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $17 → $18 | Buy | Maintains | $17 → $18 | +38.14% | Nov 5, 2025 |
Financial Forecast
Revenue This Year
874.26M
from 822.31M
Increased by 6.32%
Revenue Next Year
926.80M
from 874.26M
Increased by 6.01%
EPS This Year
-2.32
from -2.33
EPS Next Year
-1.67
from -2.32
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 906.5M | 957.6M | |||
| Avg | 874.3M | 926.8M | |||
| Low | 837.7M | 883.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.2% | 9.5% | |||
| Avg | 6.3% | 6.0% | |||
| Low | 1.9% | 1.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.38 | -1.72 | |
| Avg | -2.32 | -1.67 | |
| Low | -2.22 | -1.61 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.